The Critical Blood-Sparing Effect of Tranexamic Acid (TXA) in Liposuction : A Systematic Review and Meta-Analysis
© 2023 The Authors..
Introduction: Tranexamic acid (TXA) has been used to improve bleeding outcomes in many surgical procedures. However, its blood-sparing effect in liposuction is not well established.
Methods: A systematic literature search was performed using PubMed, Embase, Cumulated Index to Nursing and Allied Health Literature (CINAHL), Cochrane Central, ClinicalTrials.gov, and WorldWideScience.org databases from their inception to October 8, 2021, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The authors focused on 3 main topics: 1) TXA, 2) liposuction, and 3) complications. We included articles evaluating the potential blood-sparing effects of TXA in liposuction. Studies were excluded if they were systematic review articles or protocol papers, animal studies, conference abstracts, survey studies, or non-English publications.
Results: A total of 711 articles were identified, with 1 retrospective and 4 prospective (3 randomized) studies meeting our inclusion criteria. TXA was used in various forms: administered intravenously either on induction or after the procedure, mixed into the tumescent solution, or infiltrated into the liposuction sites after lipoaspiration. A significantly smaller reduction in hematocrit was noted in the TXA group compared with that in the non-TXA group (p<0.001) despite a significantly greater amount of lipoaspirate removed in the TXA group (p<0.001). Patients in non-TXA cohorts experienced adverse effects (such as seroma and need for transfusion) that were not seen in TXA cohorts.
Conclusion: TXA use in patients undergoing liposuction seems to be associated with a beneficial blood-sparing effect, which may enhance safety in this population. Future studies should aim to determine the optimal route and dosing for TXA in liposuction.
Evidence Based Medicine: Level IV.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
JPRAS open - 40(2024) vom: 01. März, Seite 48-58 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Reinhardt, Myrna Eliann [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Fibrinolytic |
|---|
| Anmerkungen: |
Date Revised 02.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.jpra.2023.01.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369155963 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369155963 | ||
| 003 | DE-627 | ||
| 005 | 20240302232731.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jpra.2023.01.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1314.xml |
| 035 | |a (DE-627)NLM369155963 | ||
| 035 | |a (NLM)38425698 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Reinhardt, Myrna Eliann |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Critical Blood-Sparing Effect of Tranexamic Acid (TXA) in Liposuction |b A Systematic Review and Meta-Analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. | ||
| 520 | |a Introduction: Tranexamic acid (TXA) has been used to improve bleeding outcomes in many surgical procedures. However, its blood-sparing effect in liposuction is not well established | ||
| 520 | |a Methods: A systematic literature search was performed using PubMed, Embase, Cumulated Index to Nursing and Allied Health Literature (CINAHL), Cochrane Central, ClinicalTrials.gov, and WorldWideScience.org databases from their inception to October 8, 2021, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The authors focused on 3 main topics: 1) TXA, 2) liposuction, and 3) complications. We included articles evaluating the potential blood-sparing effects of TXA in liposuction. Studies were excluded if they were systematic review articles or protocol papers, animal studies, conference abstracts, survey studies, or non-English publications | ||
| 520 | |a Results: A total of 711 articles were identified, with 1 retrospective and 4 prospective (3 randomized) studies meeting our inclusion criteria. TXA was used in various forms: administered intravenously either on induction or after the procedure, mixed into the tumescent solution, or infiltrated into the liposuction sites after lipoaspiration. A significantly smaller reduction in hematocrit was noted in the TXA group compared with that in the non-TXA group (p<0.001) despite a significantly greater amount of lipoaspirate removed in the TXA group (p<0.001). Patients in non-TXA cohorts experienced adverse effects (such as seroma and need for transfusion) that were not seen in TXA cohorts | ||
| 520 | |a Conclusion: TXA use in patients undergoing liposuction seems to be associated with a beneficial blood-sparing effect, which may enhance safety in this population. Future studies should aim to determine the optimal route and dosing for TXA in liposuction | ||
| 520 | |a Evidence Based Medicine: Level IV | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anti-Fibrinolytic | |
| 650 | 4 | |a Liposculpture | |
| 650 | 4 | |a Liposuction | |
| 650 | 4 | |a TXA | |
| 650 | 4 | |a Tranexamic Acid | |
| 700 | 1 | |a Mutyala, Sudeep |e verfasserin |4 aut | |
| 700 | 1 | |a Gerald, Mykal |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Huaqing |e verfasserin |4 aut | |
| 700 | 1 | |a Nova, Vitalina |e verfasserin |4 aut | |
| 700 | 1 | |a Araya Cambronero, Sthefano |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Sameer |e verfasserin |4 aut | |
| 700 | 1 | |a Baltodano, Pablo A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JPRAS open |d 2015 |g 40(2024) vom: 01. März, Seite 48-58 |w (DE-627)NLM259391999 |x 2352-5878 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2024 |g day:01 |g month:03 |g pages:48-58 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jpra.2023.01.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2024 |b 01 |c 03 |h 48-58 | ||